| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 10/10/2002 | DE10157882A1 Verfahren zur Herstellung von Carbonsäureamiden A process for the preparation of carboxamides |
| 10/10/2002 | CA2442363A1 Reducing the immunogenicity of fusion proteins |
| 10/10/2002 | CA2442064A1 G-protein coupled receptors |
| 10/09/2002 | EP1247818A2 Prion and viral clearance process of immunoglobulin preparations |
| 10/09/2002 | EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 10/09/2002 | EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 10/09/2002 | EP1194445A4 Methods for protein purification using aqueous two-phase extraction |
| 10/09/2002 | EP1030678A4 High throughput method for functionally classifying proteins identified using a genomics approach |
| 10/09/2002 | EP0909176B1 Reactor and method for solid phase peptide synthesis |
| 10/09/2002 | EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient |
| 10/09/2002 | EP0651761B1 Method for modification of recombinant polypeptides |
| 10/09/2002 | EP0438600B2 Enzymes which participate in c-terminal amidation, and production and use thereof |
| 10/09/2002 | CN1373213A Process for extracting enzyme from egg |
| 10/09/2002 | CN1373212A Process for extracting enzyme from egg |
| 10/08/2002 | US6462181 Process for preparing a kappa-caseino glycomacropeptide or a derivative thereof |
| 10/08/2002 | US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 10/08/2002 | US6462172 Purification of tissue plasminogen activator (TPA) |
| 10/08/2002 | US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide |
| 10/08/2002 | CA2254145C Improved process to stabilize proteins |
| 10/08/2002 | CA2126680C Novel megakaryocyte potentiator |
| 10/03/2002 | WO2002077751A2 Apparatus and method for designing proteins and protein libraries |
| 10/03/2002 | WO2002077016A2 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore |
| 10/03/2002 | WO2002076927A2 Method for the production of carboxylic acid amides |
| 10/03/2002 | WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 10/03/2002 | WO2001020331A9 Substrates and screening methods for transport proteins |
| 10/03/2002 | WO2001019846A9 Transgenically produced fusion proteins |
| 10/03/2002 | US20020143207 Process for the deprotection of protected thiols |
| 10/03/2002 | US20020143158 Purification of preferential protin from sample; provide methylated aspartate ligand complexed with a transiton metal, incubate with cell lysate, elute and recover preferential protein from column |
| 10/03/2002 | US20020143153 Monitoring crystalization on microarray; generate microarray, incubate with sample of mother liquor, detect crystal formation in the drops, take images of drops |
| 10/03/2002 | US20020143144 Screening of drugs from chemical combinatorial libraries employing transponders |
| 10/03/2002 | US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses |
| 10/03/2002 | US20020142394 Exonuclease-mediated gene assembly in directed evolution |
| 10/03/2002 | US20020142384 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein |
| 10/03/2002 | US20020142369 Refolding method of thrombin |
| 10/03/2002 | US20020142355 Methods for the in vivo biotin labeling of polypeptides |
| 10/03/2002 | US20020142346 Binding compounds and methods for identifying binding compounds |
| 10/03/2002 | US20020141905 Protein solution and the reagent solution within the first well interact with the reagent solution within the second well via vapor diffusion which enables the formation of protein crystal within the first well |
| 10/03/2002 | CA2504413A1 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore |
| 10/02/2002 | EP1244702A2 A process for isolation of osteopontin from milk |
| 10/02/2002 | EP0792281B1 Process for purification of factor viii |
| 10/02/2002 | EP0758349B1 Surface-modifying endgroups for biomedical polymers |
| 10/02/2002 | EP0691988B1 Inhibitor of stem cell proliferation and uses thereof |
| 10/02/2002 | DE10116252A1 New 2-aryl-2-triorganylsilylether compounds useful for the solid phase synthesis of peptides and peptide conjugates, may be cleaved from the solid phase substrate under practically neutral conditions |
| 10/02/2002 | DE10112002A1 New de novo protein domain, useful for purification of recombinant proteins by affinity chromatography, includes tag attached to an alpha helix to ensure accessibility |
| 10/02/2002 | CN1372570A Modified exendin and exendin agonists |
| 10/02/2002 | CN1371914A Cockroach polypeptide tracted from cockroach and extraction method thereof |
| 10/01/2002 | US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 10/01/2002 | US6458931 Immunoassay, immunotherapy; cancer; side effect reduction |
| 10/01/2002 | US6458381 Lipids and their use, for example, in liposomes |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2124087C Combinatorial strategies for polymer synthesis |
| 10/01/2002 | CA2109602C Methods for producing members of specific binding pairs |
| 10/01/2002 | CA2077670C Method for enhancing antibody transport through capillary barriers |
| 10/01/2002 | CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them |
| 10/01/2002 | CA2069256C Method of preparing .alpha.-l-aspartyl-l-phenylalanine methyl ester |
| 10/01/2002 | CA1341390C Human protein disulfide isomerase polypeptide and dna encoding the same |
| 09/26/2002 | WO2002074927A2 High accuracy protein identification |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074791A1 Method for purification of molecules using unbranched terminal alkyldiols |
| 09/26/2002 | WO2002074784A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 09/26/2002 | WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | WO2002074158A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | WO2002053252A3 A method for mixed mode adsorption and mixed mode adsorbents |
| 09/26/2002 | WO2002004481A3 Process to increase protein stability |
| 09/26/2002 | WO2001019484A9 Purification device and purification method |
| 09/26/2002 | US20020137902 Method for producing crystal polymorphs and crystal polymorphs produced thereby |
| 09/26/2002 | US20020137893 Purification of NGF |
| 09/26/2002 | US20020137891 Inserting a nucleic acid sequence encoding a heterologous polypeptide into a nucleic acid sequence encoding subunit of an oligomerisable protein scaffold, incorporating it into expression vector to express nucleic acid to produce monomer |
| 09/26/2002 | US20020137884 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 09/26/2002 | US20020137730 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137205 Lipid uptake assays |
| 09/26/2002 | US20020137177 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme |
| 09/26/2002 | US20020137157 Adjusting total protein concentration in mixture to 0.01-500 mg/mL, adding chaotropic agent at concentration of 0 M to 8 M, concentration of agent being limited to provide for retention of biological activity of protein, incubating under pressure |
| 09/26/2002 | US20020137156 Controlled dissolution crosslinked protein crystals |
| 09/26/2002 | US20020137119 Immunoassay; quantitative analysis |
| 09/26/2002 | US20020137118 Drug desin |
| 09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
| 09/26/2002 | US20020137085 Multiplexed generation of chemical or physical events |
| 09/26/2002 | US20020137059 Microdevice containing photorecognizable coding patterns and methods of using and producing the same thereof |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2440749A1 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243262A1 Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
| 09/25/2002 | EP1242825A2 Extraction of biological components from body fluids |
| 09/25/2002 | EP1242823A2 Selecting library members capable of binding to epitopes |
| 09/25/2002 | EP1242815A1 The manufacture of improved support matrices |
| 09/25/2002 | EP1242610A1 Method for extractive refolding of scrambledsingle-chain polypeptides |
| 09/25/2002 | EP1242594A1 Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
| 09/25/2002 | EP1242177A1 Method and device for the mask-free production of biopolymers by means of a light diode array |
| 09/25/2002 | EP0912470B9 Method and device for purifying and enriching molecules |
| 09/25/2002 | EP0871656B1 Dolastatin derivatives, their preparation and use |
| 09/25/2002 | CN1371303A Method and device for performing operations at charged microlocations |
| 09/25/2002 | CN1370832A Membrane-associated sphingomyelinase derived from ox brain, its separation process and sphingomyelinase-resisting monoclonal antibody |
| 09/24/2002 | US6455705 Distillation-free; chemical intermediates for the production of angiotensin-converting enzyme (ace) inhibitors |
| 09/24/2002 | US6455273 Contacting protein with thiol protease obtainable from germinating soybean cotyledons to produce protein hydrolyzate with reduced bitterness and content of free amino acids, incorporating into food product |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |